| 141 |
Hematopoietic Recovery after in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant-Effects of Major ABO Incompatibility, CMV Viremia and Acute Gvhd |
2018 |
| 142 |
Impact of CD39 expression on CD4+ T lymphocytes and 6q deletion on outcome of patients with chronic lymphocytic leukemia |
2018 |
| 143 |
Impact of CD39 expression on CD4+ T lymphocytes and 6q deletion on outcome of patients with chronic lymphocytic leukemia |
2018 |
| 144 |
Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post‐transplant |
2018 |
| 145 |
Long-Term Acid Suppressive Therapy among Naïve
Patients with Mycobacterium Tuberculosis Infection |
2018 |
| 146 |
Lower transcranial Doppler flow velocities in sickle cell anemia patients on hydroxyurea: myth or fact |
2018 |
| 147 |
Lower transcranial Doppler flow velocities in sickle cell anemia patients on hydroxyurea: myth or fact |
2018 |
| 148 |
More about Cyclosporine A as a Monotherapy in Aplastic Anemia Patients; A Single Center Experience |
2018 |
| 149 |
More about Cyclosporine A as a Monotherapy in Aplastic Anemia Patients; A Single Center Experience |
2018 |
| 150 |
More about Cyclosporine A as a Monotherapy in Aplastic Anemia Patients; A Single Center Experience |
2018 |